The Dual Incretin
Tirzepatide · Injection
A dual GIP and GLP-1 receptor agonist studied for appetite regulation, insulin sensitivity, and sustainable body-weight reduction.
Starting at
$299/ month
Prefer to talk first? Talk to a licensed provider.
Why it matters
What the research shows
- Studied for clinically significant body-weight reduction (SURMOUNT trial program)
- Targets both GIP and GLP-1 receptors for amplified metabolic effect
- Researched for improvements in fasting glucose and HbA1c
- Explored for cardiometabolic markers and inflammation
- May reduce food noise and cravings between meals
How it works
From consult to doorstep
01
Medical intake
A short clinical questionnaire reviewed by a licensed prescriber in your state.
02
Provider review
Your clinician confirms eligibility and tailors your starting dose.
03
Shipped to you
Compounded by a licensed pharmacy, shipped cold-chain to your door.
04
Ongoing titration
Check-ins and dose adjustments — we stay until it works.
For educational reference only — not medical advice. Loop does not diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA. Your protocol is built with a licensed Loop clinician based on your goals, history, and labs.